Co-Diagnostics, Inc.
NASDAQCo-Diagnostics reports after the bell today. The lending market tells a striking pre-earnings story. Availability has fallen to near-zero. With 93.51% of the lending pool already lent out, only about one share remains available for every fourteen already borrowed. That's close to the 52-week peak of 100% utilisation — the tightest the borrow market…
CODX short interest utilization hits 93.51%, near 52-week high of 100%, as shares to borrow tighten significantly.
Short interest % of float, cost to borrow, utilization, and put/call ratio for CODX are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 14 May 2026
Co-Diagnostics reports after the bell today. The lending market tells a striking pre-earnings story. Availability has fallen to near-zero. With 93.51% of the lending pool already lent out, only about one share remains…
Co-Diagnostics heads into its May 14 earnings report with its lending market under the most stress it has seen in months — and the short score to match. The borrow market tells the sharpest story. Cost to borrow has…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CODX — free to start on ORTEX.
Sign up for free →Open CODX on ORTEX